More preliminarily, the specific neutralization of catalytically inactive TG2 on the surface of epithelial cells mitigates certain features of disease ex vivo [152], and may represent another therapeutic inroad once this enigmatic new role for TG2 in celiac sprue pathogenesis is elucidated. The gene discussed is TGM2; the disease is celiac disease.